Cytosorbents Corporation CTSO
4.12 USD -0.42 -9.25%
At close · Nov 2
4.65 +0.53 +12.86%
After hours · Nov 2, 4:00 PM ET
- YTD
- -67.76%
- 1 year
- -74.09%
- Open
- 4.54
- Prev close
- 4.54
- Mkt cap
- 12.98M
- Vol
- 24.32K
- Avg vol
- 33.53K
- EPS
- -5.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.76
- High
- 4.74
- Forward P/E
- -5.99
- Beta
- 0.56
- Short ratio
- 9.57
- Inst. own
- 33.29%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.95762
- 200-d avg
- 0.981655
- 1y target
- 5.00
5D chart
Chart tools
Chart is warming up
The five-day price history for CTSO has not been loaded yet. Try again in a moment.
Altman Z-Score
-12.27 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -4.9×
P/S 1.1×
P/B 6.7×
P/FCF -3.2×
EV/EBITDA -14.4×
EV/Sales 1.7×
FCF Yield -31.5%
Gross Margin 71.5%
Operating Margin -38.4%
Net Margin -22.1%
ROE -138.9%
ROIC -38.8%
ROA -18.6%
Revenue 4.1%
Operating Income 13.5%
EPS (diluted) 65.8%
Free Cash Flow 14.8%
Current Ratio 2.1×
Quick Ratio 1.6×
Debt / Equity 4.9×
Net Debt / EBITDA -5.2×
Interest Coverage -5.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31